Stomach cancer
hideStomach or gastric cancer can develop in any part of the stomach and may spread throughout the stomach and to other organs; particularly the esophagus, lungs and the liver. Stomach cancer causes about 800,000 deaths worldwide per year.
For more information about Stomach cancer, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with gastric cancer
Is short-term Celecoxib intervention a effective method for preventing gastric carcinogenesis?
Oct 28, 2009 |
not rated yet |
0
Helicobacter pylori has been accepted as an important pathogen inducing gastric cancer. A research group from Taiwan investigated optimal intervention point of Celecoxib, to inhibit H. pylori-associated gastric carcinogenesis ...
A new explanation of 'Asian paradox'
Oct 28, 2009 |
3 / 5 (1) |
1
There is abundant evidence of an association between Helicobacter pylori chronic infection and gastric cancer. The incidence of gastric cancer is much higher in Japan than Indonesia. A research from Indonesia and Japan found ...
Duke/Singapore scientists find new way to classify gastric cancers
Oct 02, 2009 |
not rated yet |
1
An international team of scientists has discovered a new way to classify stomach cancers, and researchers say it may be an important step toward designing more effective treatments and improving long-term survival.
Study shows use of Herceptin in treatment of stomach cancer prolongs life
Sep 25, 2009 |
not rated yet |
0
(PhysOrg.com) -- A study involving a University of Glasgow cancer specialist has found that using Herceptin increases survival rates among those with stomach cancer.
Does Helicobacter pylori eradication therapy prevent gastric cancer?
Sep 25, 2009 |
4 / 5 (1) |
0
Although it has been demonstrated that Helicobacter pylori causes gastric cancer, it is still controversial that whether H. pylori eradication therapy is effective in primary prevention of gastric cancer. This is especially ...
D2 lymphadenectomy improves the long-term survival for patients with node-negative gastric cancer
Aug 26, 2009 |
not rated yet |
1
Many studies favor an extended lymphadenectomy at the time of a potentially curative gastrectomy for node-positive gastric cancer, and the risk of long-term death tends to decrease when the number of resected lymph nodes ...
Fecal DNA methylation detects gastric and colorectal cancers
Aug 21, 2009 |
5 / 5 (1) |
0
A preliminary evaluation of methylation of two gene promoters in fecal DNA showed promise as a noninvasive method to detect colorectal and gastric cancers, according to a new study published online August 21 in the Journal of ...
Improving postoperative quality of life in gastric cancer patients by a special reconstruction method
Jul 16, 2009 |
1 / 5 (1) |
0
Given equivalent results with regards to survival, the impact of anastomotic methods on QOL becomes even more important. There is still no consensus on how to choose a reconstruction method for proximal gastrectomy in patients ...
A potent and selective anti-tumor agent on human gastric cancer
Jun 29, 2009 |
not rated yet |
1
A research article to be published on June 21, 2009 in the World Journal of Gastroenterology addresses this question. The research team led by Professor Yan Li from Shengjing Hospital of China Medical University studied the gr ...
Tummy troubles -- gastrin key in bacterial-induced stomach cancer
Jun 24, 2009 |
4.3 / 5 (3) |
0
Current research suggests that levels of gastrin play a key role in the development of Helicobacter-induced stomach cancer. The related report by Takaishi et al, "Gastrin is an essential cofactor for Helicobacter-associated gastric corpu ...
A breakthrough in gastric carcinogenesis
Jun 11, 2009 |
not rated yet |
0
Checkpoint with forkhead and ring finger (CHFR) is a mitotic stress checkpoint gene whose promoter is frequently methylated in various kinds of cancer. In gastric cancer, CHFR promoter hypermethylation has been reported to ...
Herceptin extends life of patients with terminal stomach cancer, study finds
Jun 01, 2009 |
not rated yet |
0
(PhysOrg.com) -- Breast cancer drug Herceptin can extend the lives of patients with incurable stomach cancer by nearly three months, according to an international study involving researchers from the University of Glasgow.
New clues on the link between Heliobacter pylori and stomach cancer
May 08, 2009 |
5 / 5 (1) |
0
Heliobacter pylori (H. pylori) infection is considered one of the most important risk factors for stomach (or gastric) cancer with as much as 65% of all cases linked back to the bacteria, although exactly ...
New minimally invasive surgery option for patients with stomach cancer
Apr 15, 2009 |
not rated yet |
0
A novel, minimally invasive surgical approach to treat stomach cancer has been shown to have advantages that may make it a preferable treatment for some patients.
A new molecular marker of gastric cancer
Mar 30, 2009 |
not rated yet |
0
Gastric cancer (GC) is one of the most common malignancies in the world with a high incidence and death rate. TNM staging system is used worldwide to predict prognosis and direct therapeutic decisions of patients with GC. ...
